Danielp Finke News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Danielp finke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Danielp Finke Today - Breaking & Trending Today
CVS Health (NYSE:CVS – Get Rating) issued an update on its FY 2022 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $8.20-$8.40 for the period, compared to the consensus estimate of $8.36. The company issued revenue guidance of -. Shares of NYSE:CVS opened at $91.45 on Thursday. The company […] ....
Equities researchers at Loop Capital began coverage on shares of CVS Health (NYSE:CVS – Get Rating) in a research report issued to clients and investors on Thursday, The Fly reports. The firm set a “buy” rating on the pharmacy operator’s stock. A number of other analysts also recently issued reports on the company. Deutsche Bank […] ....
CVS Health (NYSE:CVS – Get Rating) updated its FY22 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $8.20-8.40 for the period, compared to the consensus estimate of $8.41. CVS Health also updated its FY 2022 guidance to $8.20-$8.40 EPS. Shares of CVS stock traded up $0.23 during trading hours on […] ....
Analysts forecast that CVS Health Co. (NYSE:CVS – Get Rating) will post $76.53 billion in sales for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for CVS Health’s earnings. The lowest sales estimate is $76.17 billion and the highest is $76.82 billion. CVS Health reported sales of $72.62 billion during the […] ....
CVS Health (NYSE:CVS – Get Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $8.20-$8.40 for the period, compared to the consensus estimate of $8.27. The company issued revenue guidance of -. Shares of CVS traded down $1.83 on Monday, reaching $98.86. […] ....